Ignite Creation Date:
2025-12-25 @ 1:23 AM
Ignite Modification Date:
2025-12-29 @ 5:30 AM
Study NCT ID:
NCT00077493
Status:
SUSPENDED
Last Update Posted:
2007-12-28
First Post:
2004-02-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
BL22 Immunotoxin In Treating Young Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Non-Hodgkin's Lymphoma
Sponsor:
MedImmune LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CDR0000352020
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Karen Kaucic, M.D.
Old Organization:
MedImmune Inc.
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |